港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

药捷安康-B

192.000

+19.30011.18%

成交量：786.06万

成交额：15.32亿

市值：762.24亿

市盈率：-244.80

高：217.000

开：169.000

低：168.900

收：172.700

52周最高：679.500

52周最低：20.200

股本：3.97亿

香港流通股本：3.02亿

量比：1.20

换手率：2.61%

股息：- -

股息率：- -

每股收益(LYR):-0.784

净资产收益率：-39.08%

总资产收益率：-21.10%

市净率：120.12

市盈率(LYR):-244.80

市销率: - -

数据加载中...

总览公司新闻公告

港股生物医药板块盘中涨幅扩大，药捷安康-B涨超25%

老虎资讯综合

生物医药行业定期：看好创新药产业趋势，关注ESMO和医保谈判

创新药出海遭“退货”第一课：诺和诺德 x KBP 13亿美元交易变欺诈指控的6条启示

A股霸屏前三，创业板指狂飙50%牛冠全球！俄股垫底

比寒武纪还离谱，主营收入0，市值炒到2700亿

从百亿到千亿，药捷安康发生了什么？

药捷安康股价坐上过山车 “妖股”背后业绩成色几何？

药捷安康-B09月24日主力净流出70.1万元散户资金买入

药捷安康-B盘中强势拉升涨超18%！该股上市至今累涨逾1200%

老虎资讯综合

医药生物行业专题研究：创新药产业趋势已成进军全球商业化

坐上港股过山车，药捷安康的意外还会重演吗？

复盘药捷安康-B事件始末...

药捷安康-B09月22日遭主力抛售58.0万元

千亿市值背后：一家“三无”Biotech的资本狂飙与泡沫隐忧

一周港股牛熊榜 | 机器人概念股掀涨势，德昌电机本周飙升40%；山高控股暴跌80%，港证监曾点名股权高度集中

老虎资讯综合

药捷安康-B：2025中期报告

香港交易所

药捷安康-B09月19日遭主力抛售750.6万元

“妖股”熄火，药捷安康尾盘跌幅扩大至18%

老虎资讯综合

港股异动 | 药捷安康-B(02617)尾盘跌近18% 较周二高点已跌超77% 总市值已不足600亿港元

药捷安康-B持续走低，日内跌幅扩大至16.5%

每日经济新闻

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02617/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":192,"timestamp":1761120495743,"preClose":172.7,"halted":0,"volume":7860556,"delay":0,"floatShares":301666673,"shares":397000000,"eps":-0.7843128385537675,"marketStatus":"已收盘","change":19.3,"latestTime":"10-22 16:08:15","open":169,"high":217,"low":168.9,"amount":1531610059,"amplitude":0.278518,"askPrice":192.1,"askSize":3000,"bidPrice":192,"bidSize":28500,"shortable":0,"etf":0,"ttmEps":-0.6766218146830053,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1761183000000},"marketStatusCode":5,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":172.7,"openAndCloseTimeList":[[1761096600000,1761105600000],[1761109200000,1761120000000]],"volumeRatio":1.195962,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-21.10%","roe":"-39.08%","lyrEps":-0.784313,"volumeRatio":1.195962,"shares":397000000,"dividePrice":0,"high":217,"amplitude":0.278518,"preClose":172.7,"low":168.9,"week52Low":20.2,"pbRate":"120.12","week52High":679.5,"institutionHeld":0,"latestPrice":192,"committee":0.809524,"eps":-0.7843128385537675,"divideRate":0,"volume":7860556,"delay":0,"ttmEps":-0.6766218146830053,"open":169,"prevYearClose":13.15,"prevWeekClose":203,"prevMonthClose":141.2,"prevQuarterClose":141.2,"fiveDayClose":113.5,"twentyDayClose":147.7,"sixtyDayClose":38.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-10-21","current":-292.069509,"percent":0.035714,"low":-380.446233,"twenty":-184.903189,"median":-58.041658,"eighty":-41.987471,"high":-17.403134,"avg":-102.901877,"sd":82.505554,"marketCap":68544221219},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-21","current":-264.885138,"twenty":-184.903189,"median":-58.041658,"eighty":-41.987471,"marketCap":68544221219}],"updateTime":1761109138329},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1116032204","title":"港股生物医药板块盘中涨幅扩大，药捷安康-B涨超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116032204","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116032204?lang=zh_cn&edition=fundamental","pubTime":"2025-10-16 10:33","pubTimestamp":1760581994,"startTime":"0","endTime":"0","summary":"10月16日，港股生物医药股集体拉升，$映恩生物-B(09606)$涨超6%，$复宏汉霖(02696)$、$博安生物(06955)$、$基石药业-B(02616)$涨超5%，$康方生物(09926)$、$荣昌生物(09995)$、$维升药业-B(02561)$、$君实生物(01877)$涨超3%.","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"68a44e2aeed9ba7083b4ebfed1ca6b2b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02696","02617","09926"],"gpt_icon":0},{"id":"2575216919","title":"生物医药行业定期：看好创新药产业趋势，关注ESMO和医保谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=2575216919","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575216919?lang=zh_cn&edition=fundamental","pubTime":"2025-10-14 20:05","pubTimestamp":1760443555,"startTime":"0","endTime":"0","summary":"臂的亨廷顿基因上的CAG三核苷酸异常扩增突变所致，通常在发病后15-20年内死亡。此外，Zenas还获得两款临床前分子相关权益。行业观点及中长期策略：我们认为中国创新药正在“量变引起质变”，看好创新药5-10年的产业趋势，BD出海、持续数据催化和新产品销售放量将依次推动创新药崛起，建议关注康方生物、百济神州、信达生物和康弘药业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014200617a45f8cf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014200617a45f8cf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","00867","02617","01167","06160","01952","02171","01672","06978","02509","01276","01177","BK1574","09688","01093","BK1161","09969","00512","02696","09606"],"gpt_icon":1},{"id":"2572577430","title":"创新药出海遭“退货”第一课：诺和诺德 x KBP 13亿美元交易变欺诈指控的6条启示","url":"https://stock-news.laohu8.com/highlight/detail?id=2572577430","media":"Jo的随笔","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572577430?lang=zh_cn&edition=fundamental","pubTime":"2025-10-03 14:33","pubTimestamp":1759473213,"startTime":"0","endTime":"0","summary":"然而，仅15个月后，该药物因III期临床试验未达终点被终止开发，诺和诺德计提8.2亿美元减值，并对KBP及其创始人黄振华发起索赔8.3亿美元的法律诉讼，新加坡法院随后批准了全球资产冻结令。诺和诺德与KBP的纠纷并非孤例。KBP称警告未被充分沟通，诺和诺德则认为KBP故意隐瞒。诺和诺德披露：KBP在交易后向控股公司转移3.39亿美元并派发5.79亿美元股息，主张其“意图逃避索赔”。诺和诺德高管甚至暗示KBP自2020年以来就在进行一场漫长的骗局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003150203a452163d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003150203a452163d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","01276","02617","01530","LU0154236417.USD","LU1093756325.SGD","LLY","IE00BZ1G4Q59.USD","BK4588","NVO","09926","LU1093756168.USD","BK4585","MRK","BK4599","01541","IE00BKVL7J92.USD","BK4532","PFE","06160"],"gpt_icon":1},{"id":"2571731349","title":"A股霸屏前三，创业板指狂飙50%牛冠全球！俄股垫底","url":"https://stock-news.laohu8.com/highlight/detail?id=2571731349","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571731349?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 18:58","pubTimestamp":1759229935,"startTime":"0","endTime":"0","summary":"“科技牛”势不可挡","market":"us","thumbnail":"https://img3.gelonghui.com/42070-59b63701-0dee-4b06-a283-bbace9fd2bac.jpg?guru_height=733&guru_width=1280&guru_size=77630","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/42070-59b63701-0dee-4b06-a283-bbace9fd2bac.jpg?guru_height=733&guru_width=1280&guru_size=77630"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2935376","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["YXI","CNmain","HSCEI","000300.SH","YANG","XPP","HSTECH","000016.SH","BK4614","510050","512550","BK1161","FXP","02617","510030"],"gpt_icon":1},{"id":"2571360804","title":"比寒武纪还离谱，主营收入0，市值炒到2700亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2571360804","media":"搜狐新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571360804?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 11:59","pubTimestamp":1759118340,"startTime":"0","endTime":"0","summary":"寒武纪好歹主营业务有20多亿收入，而药捷安康主营业务收入为0元，市值却一度逼近2700亿。市场规模方面，2024年全球CCA药物市场规模为20亿美元，前列腺癌药物市场规模为193亿美元，预计2027年将分别增长至32亿美元、249亿美元。今年上半年，研发费用进一步下降到9840万元，较去年同期减少30.9%。2023年亏损3.43亿元，2024年亏损2.75亿元，今年上半年继续亏损1.23亿元。若60个工作日内未提出反对意见，则","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929153912954bc685&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929153912954bc685&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2570054906","title":"从百亿到千亿，药捷安康发生了什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2570054906","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570054906?lang=zh_cn&edition=fundamental","pubTime":"2025-09-25 12:13","pubTimestamp":1758773629,"startTime":"0","endTime":"0","summary":"文｜《投资者网》蔡俊9月，药捷安康成了创新药“显眼包”。同时，公司与LG Chem共同宣布VAP-1抑制剂在美国成功实现首例受试者给药。千亿市值的是与非从默默无闻到人尽皆知，药捷安康只用了三个月。这种大开大合的剧情，公司发布公告表示，不知悉异常变动的任何原因，集团营运维持正常，财务状况无重大变动。截至目前，公司96.2%的股份由上市前投资者锁定，IPO发行股份占总股本的3.8%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1758765218687809540","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2570734051","title":"药捷安康股价坐上过山车 “妖股”背后业绩成色几何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2570734051","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570734051?lang=zh_cn&edition=fundamental","pubTime":"2025-09-25 11:38","pubTimestamp":1758771503,"startTime":"0","endTime":"0","summary":"从消息面来看，药捷安康此轮股价的抬升与公司核心产品的临床进展相关。扣除基石投资者认购部分及原股东持股后，药捷安康在二级市场上的实际可自由交易的流通股仅约549万股。截至2025年6月30日，药捷安康账上现金及现金等价物同比减少21%至4.49亿元。当前药捷安康的市值已经回落至590亿港元，相较于高峰期的市值下跌近八成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925114347a69ca5be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925114347a69ca5be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2569774540","title":"药捷安康-B09月24日主力净流出70.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2569774540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569774540?lang=zh_cn&edition=fundamental","pubTime":"2025-09-24 16:15","pubTimestamp":1758701731,"startTime":"0","endTime":"0","summary":"09月24日, 药捷安康-B股价跌1.57%，报收162.50元，成交金额4.1亿元，换手率0.80%，振幅12.72%，量比0.35。药捷安康-B今日主力资金净流出70.1万元，上一交易日主力净流入277.7万元。该股近5个交易日下跌22.28%，主力资金累计净流出1793.5万元；近20日主力资金累计净流出1438.8万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092417094095421347&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092417094095421347&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"1176140056","title":"药捷安康-B盘中强势拉升涨超18%！该股上市至今累涨逾1200%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176140056","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176140056?lang=zh_cn&edition=fundamental","pubTime":"2025-09-23 09:57","pubTimestamp":1758592660,"startTime":"0","endTime":"0","summary":"9月23日，$药捷安康-B(02617)$盘中强势拉升，现涨超18%！该股上市至今累涨逾1200%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9f571b022481e7a7a299180f01a8da28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4614","02617"],"gpt_icon":0},{"id":"2569951627","title":"医药生物行业专题研究：创新药产业趋势已成 进军全球商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2569951627","media":"天风证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569951627?lang=zh_cn&edition=fundamental","pubTime":"2025-09-23 00:00","pubTimestamp":1758556800,"startTime":"0","endTime":"0","summary":"中国已成为全球靶点验证到IND路径中效率最高的国家之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923170635953fc337&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923170635953fc337&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02616","02696","06160","06978","02617","01801"],"gpt_icon":1},{"id":"2569394637","title":"坐上港股过山车，药捷安康的意外还会重演吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2569394637","media":"药闻社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569394637?lang=zh_cn&edition=fundamental","pubTime":"2025-09-22 22:56","pubTimestamp":1758553007,"startTime":"0","endTime":"0","summary":"在2025年下半年这波港股创新药的强势回暖行情中，一家名为药捷安康的公司，在股价火箭式飞升后用迅速掉落。股价波动剧烈的直接原因，在于国证港股通创新药指数实施季度定期调整，并将药捷安康纳入进去，大批被动资金卷入。在这一系列的推动下，药捷安康的股价正式起飞。9月16日，药捷安康在盘中创下679.5港元的历史高点，市值接近2700亿港元。因此，造成市值蒸发悲剧的，不仅有过小的流通盘，还有药捷安康过早的上市时间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923000335a43cc7ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923000335a43cc7ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSCEI","HSTECH","02617","BK1161"],"gpt_icon":1},{"id":"2569200975","title":"复盘药捷安康-B事件始末...","url":"https://stock-news.laohu8.com/highlight/detail?id=2569200975","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569200975?lang=zh_cn&edition=fundamental","pubTime":"2025-09-22 16:47","pubTimestamp":1758530836,"startTime":"0","endTime":"0","summary":"截至最新，跟踪国证港股通创新药指数的4只ETF，药捷安康的权重已被显著调低，远低于其在指数中2.6%的理论权重。目前，相关ETF已通过主动操作大幅降低了药捷安康的持仓乃至清仓，净值波动与药捷安康股价的关联性已显著减弱。此事件预计将推动市场对指数编制规则，比如新股纳入条件、流动性考量、ETF成分股流动性监测以及信息披露透明度的进一步反思和完善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922165144a43c0067&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922165144a43c0067&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2569202038","title":"药捷安康-B09月22日遭主力抛售58.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569202038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569202038?lang=zh_cn&edition=fundamental","pubTime":"2025-09-22 16:16","pubTimestamp":1758528964,"startTime":"0","endTime":"0","summary":"09月22日, 药捷安康-B股价跌1.47%，报收147.70元，成交金额5.3亿元，换手率1.17%，振幅13.94%，量比0.34。药捷安康-B今日主力资金净流出58.0万元，连续4日净流出，上一交易日主力净流出750.6万元。该股近5个交易日下跌64.43%，主力资金累计净流出3791.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1646.4万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922162413953d65d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922162413953d65d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2569727316","title":"千亿市值背后：一家“三无”Biotech的资本狂飙与泡沫隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2569727316","media":"药事纵横","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569727316?lang=zh_cn&edition=fundamental","pubTime":"2025-09-22 06:02","pubTimestamp":1758492142,"startTime":"0","endTime":"0","summary":"2025年上半年，药捷安康收入为零，期内亏损1.23亿元。截至2025年6月23日上市，公司总股本3.97亿股，其中H股3.02亿股。风险警示衡量一家Biotech公司的估值，市研率是一个关键指标。而行业平均水平，根据对多家已上市Biotech企业的统计，市研率约为12倍。回顾历史，不乏Biotech企业因估值泡沫破裂而市值大幅缩水的案例。再看2024年美股市场，Aditxt、CNS Pharmaceuticals等Biotech公司股价跌幅均超过99%。结语药捷安康的千亿市值，既是一场资本的狂欢，也是一面行业的镜子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922060551a72ddc0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922060551a72ddc0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"1184699731","title":"一周港股牛熊榜 | 机器人概念股掀涨势，德昌电机本周飙升40%；山高控股暴跌80%，港证监曾点名股权高度集中","url":"https://stock-news.laohu8.com/highlight/detail?id=1184699731","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184699731?lang=zh_cn&edition=fundamental","pubTime":"2025-09-20 09:20","pubTimestamp":1758331230,"startTime":"0","endTime":"0","summary":"自2025年9月17日至2025年11月15日面向社会公众征求意见，这意味着L2智驾新标准距离正式发布又近一步。该机构指，新标准对智驾系统安全性提出更多要求，规范DMS驾驶员监控系统，预计L2智驾准入难度或将大幅提升。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"03b5cf1bcd1337275a088b73818f952b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09678","00412","06088","06869","09969","00179","02617","00020","09866","02616","HSI"],"gpt_icon":1},{"id":"2568266461","title":"药捷安康-B：2025中期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2568266461","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568266461?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 16:42","pubTimestamp":1758271342,"startTime":"0","endTime":"0","summary":"公司核心产品替恩戈替尼正在中国进行胆管癌适应症的注册性II期临床试验，预计于2025年下半年完成；同时在美国等地区进行国际多中心III期临床试验。药捷安康于2025年上半年录得亏损1.23亿元人民币，较去年同期亏损1.60亿元收窄23.4%。公司于2025年6月23日在港交所主板上市，全球发售募集资金净额约1.61亿港元，主要用于替恩戈替尼的多区域注册III期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919213202a72a647e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919213202a72a647e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2568253748","title":"药捷安康-B09月19日遭主力抛售750.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568253748","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568253748?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 16:15","pubTimestamp":1758269738,"startTime":"0","endTime":"0","summary":"09月19日, 药捷安康-B股价跌18.18%，报收149.90元，成交金额6.4亿元，换手率1.25%，振幅21.94%，量比0.30。药捷安康-B今日主力资金净流出750.6万元，连续3日净流出，上一交易日主力净流出1192.6万元。该股近5个交易日下跌22.60%，主力资金累计净流出863.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1588.5万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919161937a436b83c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"de0c57402920c029a2335a8a6d9d3d7a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919161937a436b83c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"1156145458","title":"“妖股”熄火，药捷安康尾盘跌幅扩大至18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156145458","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156145458?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 15:51","pubTimestamp":1758268302,"startTime":"0","endTime":"0","summary":"此前一度飙升50倍。","market":"hk","thumbnail":"https://static.tigerbbs.com/bbe0dc929d5aac050fe7d1c2e15a7fa7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bbe0dc929d5aac050fe7d1c2e15a7fa7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"de0c57402920c029a2335a8a6d9d3d7a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2568580292","title":"港股异动 | 药捷安康-B(02617)尾盘跌近18% 较周二高点已跌超77% 总市值已不足600亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568580292","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568580292?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 15:45","pubTimestamp":1758267940,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药捷安康-B尾盘跌近18%，低见150.2港元，较周二盘中高点679.5港元已跌超77%。公开资料显示，药捷安康今年6月23日在港交所上市，发行价为13.15港元，总股本约3.97亿股，上市时总市值约52亿港元。9月15日，药捷安康被纳入“国证港股通创新药指数”。市场人士指出，药捷安康在指数中的初始权重约为2.63%，据推算相关指数基金需被动配置至少超过6亿港元的该股票，由此触发股价剧烈波动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"de0c57402920c029a2335a8a6d9d3d7a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1347254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02617","HSCEI","YANG","BK1161","BK4614"],"gpt_icon":0},{"id":"2568584872","title":"药捷安康-B持续走低，日内跌幅扩大至16.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568584872","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568584872?lang=zh_cn&edition=fundamental","pubTime":"2025-09-19 15:40","pubTimestamp":1758267630,"startTime":"0","endTime":"0","summary":"每经AI快讯，9月19日，药捷安康-B(02617.HK)持续走低，日内跌幅扩大至16.5%，报152.9港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509193518428293.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"de0c57402920c029a2335a8a6d9d3d7a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509193518428293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02617","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":2,"totalSize":180,"code":"91000000","status":"200"}]}}